Detail Correlation between APRI and HbA1C as a predictor of liver fibrosis (presented at The 9th Liver Update Jakarta, 20-22 May 2016) Bibliografi Author: Adi Suhanto, Marcella ; Steffanus, Mario ; Tenggara, Riki Topik: APRI; diabetes; liver fibrosis; JABFUNG-FKIK-RTG-2021-20 Bahasa: (EN )     Penerbit: Divisi Hepatobiliary, Departemen of Internal Medicine, Fakultas Kedokteran, Universitas Indonesia dan Asosiasi Indonesia untuk Studi Hati (Ina ASL / PPHI)     Tempat Terbit: Jakarta    Tahun Terbit: 2016     Jenis: Poster - pada seminar nasional Fulltext: B-20 Dokumen.pdf (1.62MB; 1 download) Abstract Backround Diabetes has been the most common cause of liver disease nowadays. By the increasing number of diabetes mellitus, concerning of liver fibrosis need to be detected more early. In Indonesia, screening for liver fibrosis is still expensive. APRI as a non-invasive marker for liver fibrosis might be an alternative tools for this. Methods This was a single-center cross sectional study carried out in 70 diabetic patients hospitalized at Atma Jaya Hospital from 2013 to 2015. APRI was used as the tool for screening liver fibrosis. HbA1C was used to determined control status of diabetes mellitus. Statistic analyses were performed using SPSS.15. Correlation was evaluated by the Spearman correlation coefficient. Results Seventy diabetic patients were enrolled for this study, 51% (36) was male. The mean age was 55.1 (1583). Numeric data was obtained (p<0.05, Kolmogorov Smirnov). By using 0.45 as the cut-off point of liver fibrosis, we found positive correlation between diabetic patients and liver fibrosis (r 0.28, p<0.05, SpearmanTest). Conclusion APRI seems to be a good non-invasive method for prediction of advanced liver fibrosis in diabetic patients. Opini Anda Klik untuk menuliskan opini Anda tentang koleksi ini! Lihat Sejarah Pengadaan  Konversi Metadata   Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved